85 related articles for article (PubMed ID: 9513497)
1. [NOD mouse (non-obese diabetic mouse)].
Moriyama H; Nagata M; Yokono K
Nihon Rinsho; 1998 Jan; 56 Suppl 3():688-94. PubMed ID: 9513497
[No Abstract] [Full Text] [Related]
2. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
3. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
4. Diabetes results from a late change in the autoimmune response of NOD mice.
Gazda LS; Charlton B; Lafferty KJ
J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
[TBL] [Abstract][Full Text] [Related]
5. [An animal model of type 1 diabetes (NOD mice)].
Nagata M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():25-32. PubMed ID: 12355754
[No Abstract] [Full Text] [Related]
6. Genetic requirements for acceleration of diabetes in non-obese diabetic mice expressing interleukin-2 in islet beta-cells.
Allison J; McClive P; Oxbrow L; Baxter A; Morahan G; Miller JF
Eur J Immunol; 1994 Oct; 24(10):2535-41. PubMed ID: 7925581
[TBL] [Abstract][Full Text] [Related]
7. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
10. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
11. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
12. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
[TBL] [Abstract][Full Text] [Related]
13. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
14. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat.
Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M
J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of diabetes in the "non obese diabetic" mouse. A few recent lessons].
Saï P; Gouin E
Journ Annu Diabetol Hotel Dieu; 1997; ():189-99. PubMed ID: 9296974
[No Abstract] [Full Text] [Related]
16. [Transgenic mouse model of type 1 diabetes mellitus].
Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():70-4. PubMed ID: 12355837
[No Abstract] [Full Text] [Related]
17. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
[TBL] [Abstract][Full Text] [Related]
19. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune diabetes: the involvement of benign and malignant autoimmunity.
Dilts SM; Lafferty KJ
J Autoimmun; 1999 Jun; 12(4):229-32. PubMed ID: 10330293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
